Cargando…

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection

SIMPLE SUMMARY: The introduction of immune checkpoint inhibitors (ICI) in 2011 revolutionized the management of many solid cancers and hematological malignancies. However, there are concerns regarding the use of ICI in the era of COVID-19. We present currently available information on the pros and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gambichler, Thilo, Reuther, Judith, Scheel, Christina H., Susok, Laura, Kern, Peter, Becker, Jürgen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698088/ https://www.ncbi.nlm.nih.gov/pubmed/33207589 http://dx.doi.org/10.3390/cancers12113383

Ejemplares similares

On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
por: Gambichler, Thilo, et al.
Publicado: (2020)

Evans’ syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma
por: Gambichler, Thilo, et al.
Publicado: (2022)

Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors
por: Gambichler, T., et al.
Publicado: (2022)

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
por: Gambichler, Thilo, et al.
Publicado: (2017)

The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary Results
por: Gambichler, Thilo, et al.
Publicado: (2023)

Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients
por: Gambichler, Thilo, et al.
Publicado: (2022)

The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy
por: Susok, L., et al.
Publicado: (2022)

Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
por: Susok, Laura, et al.
Publicado: (2021)

Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
por: Duarte, Nathan, et al.
Publicado: (2021)

Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients
por: Gambichler, Thilo, et al.
Publicado: (2023)

Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma
por: Gambichler, T., et al.
Publicado: (2022)

Model for End-Stage Liver Disease Correlates with Disease Relapse and Death of Patients with Merkel Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-related Endocrinopathies
por: Lu, Difei, et al.
Publicado: (2022)

Hallmarks of Resistance to Immune-Checkpoint Inhibitors
por: Karasarides, Maria, et al.
Publicado: (2022)

Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy
por: Gambichler, Thilo, et al.
Publicado: (2018)

Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
por: Burtscher, Johannes, et al.
Publicado: (2020)

Innate Immune Response in SARS-CoV-2 Infection
por: Schiuma, Giovanna, et al.
Publicado: (2022)

Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year Analysis
por: Susok, Laura, et al.
Publicado: (2021)

Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization
por: Gambichler, Thilo, et al.
Publicado: (2022)

Advances in Targeting Cutaneous Melanoma
por: Kasakovski, Dimitri, et al.
Publicado: (2021)

SARS-CoV-2 infection and the antiviral innate immune response
por: Yang, Hui, et al.
Publicado: (2020)

Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021)

Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
por: Loas, Gwenolé, et al.
Publicado: (2021)

Cross-reactive memory T cells and herd immunity to SARS-CoV-2
por: Lipsitch, Marc, et al.
Publicado: (2020)

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021)

Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes
por: Gambichler, Thilo, et al.
Publicado: (2022)

Immune checkpoint inhibitors win the 2018 Nobel Prize
por: Huang, Pei-Wei, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective Affinities
por: Rizzo, Alessandro
Publicado: (2022)

Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research
por: Cheung, Yee-Ming M, et al.
Publicado: (2023)

Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results
por: Gambichler, Thilo, et al.
Publicado: (2019)

Hypereosinophilic syndrome complicated by severe vascular damage and gangrene
por: Gambichler, Thilo, et al.
Publicado: (2019)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection
por: Yatim, Nader, et al.
Publicado: (2021)

Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
por: Netea, Mihai G., et al.
Publicado: (2020)

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
por: Xia, Shuai, et al.
Publicado: (2022)

SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
por: Adashi, Eli Y., et al.
Publicado: (2022)

Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges
por: Wu, Tangchun
Publicado: (2020)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

Virus-Induced CD8(+) T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic
por: Federico, Maurizio
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_33e32fj4jmiuihnctud3q0pasc